|
ZNF322B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50556999999329E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.612900E-04 |
| Normal-vs-Stage2 |
3.351500E-04 |
| Normal-vs-Stage3 |
4.41960000000519E-05 |
| Normal-vs-Stage4 |
1.767170E-04 |
| Stage1-vs-Stage2 |
1.871000E-01 |
| Stage1-vs-Stage3 |
2.194800E-01 |
| Stage1-vs-Stage4 |
1.701210E-01 |
| Stage2-vs-Stage3 |
6.933400E-01 |
| Stage2-vs-Stage4 |
9.955400E-01 |
| Stage3-vs-Stage4 |
6.761600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.22779999994971E-06 |
| Normal-vs-AfricanAmerican |
1.957570E-02 |
| Normal-vs-Asian |
1.644370E-01 |
| Caucasian-vs-AfricanAmerican |
4.186200E-01 |
| Caucasian-vs-Asian |
1.022060E-02 |
| AfricanAmerican-vs-Asian |
2.871400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.236760E-04 |
| Normal-vs-Female |
1.95266999999388E-05 |
| Male-vs-Female |
8.475200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.422800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.50963999999698E-05 |
| Normal-vs-Age(61-80Yrs) |
2.834800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.091530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.405800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.221200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.598580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.447800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.183200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.318800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.144800E-01 |
| Classical-VS-Follicular |
3.333000E-01 |
| Classical-VS-Other |
3.615600E-01 |
| Classical-VS-Normal |
1.172430E-04 |
| Tall-VS-Follicular |
8.791800E-01 |
| Tall-VS-Other |
5.875800E-01 |
| Tall-VS-Normal |
8.382500E-04 |
| Follicular-VS-Other |
5.954200E-01 |
| Follicular-VS-Normal |
2.809400E-04 |
| Other-VS-Normal |
3.156300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.78450000000763E-05 |
| Normal-vs-N1 |
1.742520E-03 |
| N0-vs-N1 |
9.478600E-01 |
|
|
